A Texas cardiac subspecialty hospital with seven years of experience with extracorporeal membrane oxygenation (ECMO) changed its treatment paradigm during the COVID-19 pandemic, finding that ...
The rapid proliferation and adoption of extracorporeal therapies is driving a concomitant demand for professionals with greater experience with these technologies than they normally receive during a ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. An early hallmark of pneumonia caused by SARS-CoV-2 is severe refractory respiratory failure. Many ...
Severely ill COVID-19 patients treated with extracorporeal membrane oxygenation (ECMO) had similar survival to hospital discharge and long-term outcomes as survivors treated with mechanical ...
Registry data on nearly 7,000 patients with cardiogenic shock who received venoarterial extracorporeal membrane oxygenation (VA-ECMO) provide a peek into the therapy’s real-world results across a wide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results